Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA Splicing01:32

RNA Splicing

60.1K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.1K
Alternative RNA Splicing02:18

Alternative RNA Splicing

24.4K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
24.4K
Alternative RNA Splicing02:18

Alternative RNA Splicing

4.6K
4.6K
Pre-mRNA Processing: RNA Splicing01:36

Pre-mRNA Processing: RNA Splicing

6.4K
6.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and Radiological Outcomes of Posterior-Based Minimally Invasive Scoliosis Surgery in Young Adult Idiopathic Scoliosis: A Comparative Study Based on Age.

Operative neurosurgery (Hagerstown, Md.)·2026
Same author

Sagittal Profiles and Their Reciprocal Changes Manifesting in Proximal Junctional Kyphosis Following Deformity Correction in Adolescent Idiopathic Scoliosis.

Global spine journal·2026
Same author

Influence of acetabular dysplasia and associated radiological indicators on hip joint motion in asymptomatic individuals.

Journal of hip preservation surgery·2026
Same author

Discordance in spinopelvic alignment between weight-bearing and supine positions on three-dimensional computed tomography.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026
Same author

Safety of Pre-Operative Radiotherapy Combined With Intraoperative Radiotherapy for Retroperitoneal Sarcoma.

Journal of surgical oncology·2026
Same author

High-Speed Instance Segmentation for Endoscopic Spine Surgery: Multicenter Validation and Inference Speed Evaluation.

Global spine journal·2026

Related Experiment Video

Updated: Dec 21, 2025

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.3K

Alternative Splicing in Hepatocellular Carcinoma.

Seung Eun Lee1, Karel P Alcedo2, Hong Jin Kim3

  • 1Department of Surgery, Chung-Ang University, Seoul, Korea; Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Cellular and Molecular Gastroenterology and Hepatology
|May 12, 2020
PubMed
Summary

Alternative splicing significantly impacts hepatocellular carcinoma (HCC) development by altering gene expression. Understanding these splicing changes offers new avenues for HCC diagnosis and treatment.

Keywords:
CancerMetabolismVariantsmRNA

More Related Videos

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
11:48

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Published on: October 9, 2014

13.2K
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

14.2K

Related Experiment Videos

Last Updated: Dec 21, 2025

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.3K
Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
11:48

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Published on: October 9, 2014

13.2K
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

14.2K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Hepatocellular carcinoma (HCC) is a major cause of cancer death globally, with poor survival rates.
  • Chronic liver disease progression to HCC involves complex molecular mechanisms.
  • Alternative splicing plays a critical role in regulating gene expression and protein diversity.

Purpose of the Study:

  • To review the role of alternative splicing in HCC pathogenesis.
  • To highlight key splicing factors, RNA binding proteins, and signaling pathways involved in HCC.
  • To discuss recent research on alternative splicing in liver cancer.

Main Methods:

  • Review of primary research from the past 3-5 years.
  • Analysis of large-scale transcriptomic data in liver cancer.
  • Focused mechanistic studies on alternative splicing in HCC.

Main Results:

  • Alternative splicing globally alters genes involved in metabolism, proliferation, and apoptosis in HCC.
  • Splicing factors and RNA binding proteins are key regulators of HCC progression.
  • Dysregulated alternative splicing provides potential prognostic markers and therapeutic targets.

Conclusions:

  • Alternative splicing is a critical driver of HCC.
  • Further research into splicing mechanisms can lead to improved HCC diagnosis and management.
  • Targeting alternative splicing pathways may offer novel therapeutic strategies for HCC.